Increased risk of hearing impairment with new thyroid eye disease treatment ...Middle East

- News
Increased risk of hearing impairment with new thyroid eye disease treatment
More patients than previously reported may experience hearing symptoms such as hearing loss or muffled hearing from a new treatment for thyroid eye disease, teprotumumab (Tepezza), according to a small study presented virtually at ENDO 2021, the Endocrine Society's annual meeting.

Hence then, the article about increased risk of hearing impairment with new thyroid eye disease treatment was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Increased risk of hearing impairment with new thyroid eye disease treatment )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News